Geneos Wealth Management’s JPMorgan BetaBuilders MSCI US REIT ETF BBRE Stock Holding History
Bought
Maintained
Sold
Other funds holding BBRE
APCM
UOTTAIMCU
GEM
AWA
Geneos Wealth Management's BBRE Position: Q3 2021 in Review
Geneos Wealth Management sold out of JPMorgan BetaBuilders MSCI US REIT ETF (BBRE) in Q3 2021, closing a stake of 67 shares — an estimated $6K sold.
Geneos Wealth Management first reported a position in BBRE in Q2 2021 and held it in 1 quarter. The position peaked at $6K in Q2 2021. 37 funds tracked by Wall St. Rank hold BBRE as of Q3 2021.
- Geneos Wealth Management reported no remaining JPMorgan BetaBuilders MSCI US REIT ETF position as of Q3 2021 after selling out during the quarter.
- Geneos Wealth Management sold 67 JPMorgan BetaBuilders MSCI US REIT ETF shares in Q3 2021, an estimated $6K.
- Geneos Wealth Management first reported a position in JPMorgan BetaBuilders MSCI US REIT ETF in Q2 2021 and held it in 1 quarter.
- Geneos Wealth Management's JPMorgan BetaBuilders MSCI US REIT ETF position peaked at $6K in Q2 2021.
- 37 funds tracked by Wall St. Rank held JPMorgan BetaBuilders MSCI US REIT ETF as of Q3 2021.
Based on Geneos Wealth Management's 13F filing for Q3 2021, filed 9 Nov 2021.